1. Nebius (NBIS) failed to break the $51 resistance despite a strong recovery, with extreme valuation concerns; 2. Aggressive revenue growth and $1B convertible notes may not suffice to meet 2025 CapEx needs; 3. AI-native customer diversification faces risks from intensifying AI competition and potential growth slowdown post-2026.